HS

Harshadrai Sakarlal Joshi

Active Director Director DIN 10207506
DIN 10207506 First appointment Jun 2023 Primary industry Paper
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 2023
Shareholding value β€’β€’β€’β€’ Premium profile

About Harshadrai Sakarlal Joshi

Data last updated:

Harshadrai Sakarlal Joshi is a Director at Medhugs Pharmatech Private Limited (since 2023). The company operates in Paper.

DIN 10207506
Primary Designation Director
Industry Paper
First Appointment 20 Jun 2023
Oldest Company Age 3 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Medhugs Pharmatech Private Limited U21001GJ2023PTC142218
Director20 Jun 20232023Active

Board colleagues of Harshadrai Sakarlal Joshi

NameDINCompanyDesignation
Dharmdev Harshad Joshi10207505Medhugs Pharmatech Private LimitedDirector

Directorship timeline

Open interactive timeline →
Medhugs Pharmatech Private Limited
Premium access

Shareholding and investment profile for Harshadrai Sakarlal Joshi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Harshadrai Sakarlal Joshi

Harshadrai Sakarlal Joshi currently holds 1 directorship: Medhugs Pharmatech Private Limited (Director, since 20 Jun 2023).

Harshadrai Sakarlal Joshi was first appointed on 20 Jun 2023 as Director at Medhugs Pharmatech Private Limited.

The current boards of Harshadrai Sakarlal Joshi's companies include Dharmdev Harshad Joshi (Medhugs Pharmatech Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available